Project Grant 2152496

Award Date 2/1/22
Completion Date 1/31/25
Dollars Obligated $372K
Federal Grant Program
47.074
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
This Project Grant award, valued at $776,309.00, is funded by the Molecular Biophysics Cluster in the Division of Molecular and Cellular Biosciences of the National Science Foundation (CFDA 47.074 Biological Sciences). The project aims to push the boundaries of current technologies to explore the structural responses to chemical modifications that trigger the release of RNA polymerase II from pausing and its entry into efficient decoding of genetic information. Specifically, the investigator...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $479,924 to The Pennsylvania State University (Penn State) to study how RNA structure regulates gene expression in Escherichia coli and Bacillus subtilis. The research aims to determine the mechanisms by which RNA polymerase pausing and transcription termination are controlled by the transcription elongation factors...
This $1,079,254 National Science Foundation project grant supports research investigating mechanisms of RNA polymerase II transcription and regulation using single molecule fluorescence techniques at the University of Colorado Boulder from March 2023 through February 2027. The research will study the assembly and disassembly of key protein complexes involved in early transcription stages using microscopy to observe individual molecules. Specifically, the research will investigate how the human...
This Project Grant award from the National Science Foundation (NSF) Division of Molecular and Cellular Biosciences, under the Biological Sciences CFDA program (47.074), will investigate a novel regulatory mechanism called "RNA buffering" that maintains messenger RNA (mRNA) levels despite changes in synthesis and decay rates. The $749,978 project at the University of Utah will explore the protein-protein and protein-RNA interactions involved in this process, which challenges...
This $185,000 Project Grant award from the National Science Foundation's (NSF) Mathematical and Physical Sciences program (CFDA 47.049) supports fundamental research on the spatial-temporal orchestration of the START transition in budding yeast cells. The research aims to elucidate the molecular mechanisms that control the timing and synchrony of the G1/S transition, which is critical for regulating cell size and fitness. The work will employ experimental and modeling approaches to investigate...
This $930,000 Project Grant award from the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074) is focused on advancing the understanding of transcription fidelity mechanisms in eukaryotic RNA polymerases. The project at the University of Alabama at Birmingham (UAB) will employ transient state kinetic approaches to quantify the differences in transcription and error correction mechanisms across the three eukaryotic RNA polymerases (I, II, and III). This research aims...
The National Institute of General Medical Sciences (NIGMS) awarded a $451,802 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) program to The Pennsylvania State University (Penn State) for a 5-year project period beginning February 1, 2025. The grant supports research to investigate the structural basis and regulation of DNA transcription by cellular and multi-subunit RNA polymerase across bacteria, archaea, and eukaryotes. Key focus areas include studying the...
This Project Grant award of $272,914 from the National Science Foundation's (NSF) Division of Molecular and Cellular Biosciences (CFDA 47.074 Biological Sciences) supports research to understand how cells interpret and respond to stress signals. The primary research objectives are to examine: 1) post-transcriptional regulation of genes through mRNA stability, and 2) combinatorial regulation of genes by multiple transcription factors. The research will use experimental techniques like metabolic...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) program, provides $1,084,158 to the Regents of the University of Michigan to advance the study of RNA-protein interactions (RPIs) and RNA-binding proteins (RBPs). The key objectives of this 5-year project are to: 1) continue developing the university's live-cell RPI assay technology (RIPCA) as a scalable platform for validating and...
This Project Grant award from the National Science Foundation (NSF) Biological Sciences (CFDA 47.074) program is funding research at the Research Foundation of the City University of New York (RFCUNY), Brooklyn College, to elucidate the epigenetic mechanisms through which prions contribute to cellular adaptation in yeast. The $700,000 project, running from August 2024 to July 2027, aims to: (1) map changes in histone modifications associated with the [PIN+] prion; (2) determine the levels,...

RUI: EARLY ENDINGS - CHARACTERIZING THE ROLE OF HRP1 IN RNA POLYMERASE II TRANSCRIPTION ATTENUATION -LIFE DEPENDS ON INFORMATION STORED IN DNA, WHICH IS EXPRESSED INTO RNA AND PROTEINS THAT PERFORM CELLULAR FUNCTIONS. AN INITIAL STEP OF GENE EXPRESSION IS TRANSCRIPTION, WHERE A MOLECULAR MACHINE CALLED RNA POLYMERASE READS DNA TO SYNTHESIZE RNA. AS RNA POLYMERASE MOVES ALONG DNA, IT CAN BE INTERRUPTED BY REGULATORY STOP SIGNALS THAT TERMINATE TRANSCRIPTION PREMATURELY. DOWNREGULATION OF GENE EXPRESSION BY EARLY TRANSCRIPTION STOPPAGE OCCURS WIDELY IN CELLS RANGING FROM BACTERIA TO HUMAN, BUT THE UNDERLYING MECHANISM AND SELECTIVITY REMAINS UNCLEAR. THIS RESEARCH PROJECT WILL INVESTIGATE PREMATURE TRANSCRIPTION TERMINATION IN THE YEAST S. CEREVISIAE, A TRACTABLE MODEL FOR STUDYING MANY CONSERVED BIOLOGICAL PROCESSES. UNDERGRADUATE STUDENT RESEARCHERS WILL BE TRAINED TO USE CLASSICAL GENETICS AND MODERN BIOINFORMATIC TOOLS TO DISSECT TRANSCRIPTION STOP SIGNALS AND DISCOVER MUTANTS THAT ALTER RECOGNITION. NEW GENE TARGETS WILL BE IDENTIFIED, WITH A BROADER GOAL OF IDENTIFYING SHARED REGULATORY FEATURES. STUDENT TRAINEES WILL HAVE OPPORTUNITIES TO PRESENT THEIR WORK AT NATIONAL RESEARCH CONFERENCES AND COAUTHOR PUBLICATIONS. THIS RESEARCH WILL ALSO BE INCORPORATED INTO A CORE UNDERGRADUATE BIOLOGY LABORATORY COURSE, MOBILIZING 50 ADDITIONAL STUDENTS TO VALIDATE GENE TARGETS. COURSE RESOURCES WILL BE SHARED BROADLY SO ADDITIONAL EDUCATIONAL COMMUNITIES MAY CONTRIBUTE AND BENEFIT. PREMATURE TRANSCRIPTION TERMINATION (ATTENUATION) OF EUKARYOTIC RNA POLYMERASE II (POL II) IS MORE PREVALENT THAN ONCE APPRECIATED BUT REMAINS ILL-DEFINED. THE INVESTIGATORS HYPOTHESIZE THAT A HYBRID TRANSCRIPTION TERMINATION PATHWAY INVOLVING THE HRP1 RNA-BINDING PROTEIN AND SEN1 HELICASE CONTRIBUTES BROADLY TO YEAST POL II ATTENUATION. THIS RESEARCH PROJECT WILL GENERATE A COMPREHENSIVE GENETIC PROFILE OF TEN NEWLY IDENTIFIED ATTENUATORS AND IDENTIFY THE LARGER REPERTOIRE OF HRP1-DEPENDENT ATTENUATORS ACROSS THE YEAST GENOME. IN AIM 1, A GENETIC SELECTION WILL IDENTIFY CIS-ACTING MUTATIONS THAT DISRUPT ATTENUATOR FUNCTION IN PLASMID-BASED REPORTER GENES, FOLLOWED BY CONFIRMATION IN CRISPR-EDITED GENOMIC DNA. A GENETIC SCREEN WILL PROBE THE EFFECT OF TRANS-ACTING MUTATIONS THAT ALTER TERMINATION FACTOR RECRUITMENT, POL II CTD MODIFICATION, AND POL II PAUSING. A DIRECT MECHANISM WILL BE ASSAYED USING HRP1 MUTANTS DEFECTIVE FOR BINDING RNA OR AFFILIATED PROTEINS. IN AIM 2, AN AUXIN-INDUCIBLE DEGRON SYSTEM WILL DEPLETE HRP1, FOLLOWED BY PRECISION NUCLEAR RUN-ON SEQUENCING (PRO-SEQ) TO MONITOR GENOME-WIDE POL II READ-THROUGH DEFECTS. THIS WORK WILL INFORM ANALYSIS OF THE HRP1 ORTHOLOG HNRNPDL, A HUMAN PROTEIN THAT LIKEWISE BINDS AU-RICH RNA AND REGULATES TRANSCRIPTION. IN ADDITION, ENGINEERED ATTENUATORS MAY BE HARNESSED FOR DYNAMIC GENE CONTROL IN BIOTECHNOLOGY APPLICATIONS, INCLUDING YEAST EXPRESSION OF INDUSTRIAL ENZYMES. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.

Posted 1/20/22, 12:00 AM